Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review

Identification of non-metastatic colorectal cancer (CRC) patients with a high risk of recurrence after tumor resection is important to select patients who might benefit from adjuvant treatment. Cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) analyses after surgery are promising biomarkers to...

Full description

Bibliographic Details
Main Authors: Suzanna J. Schraa, Karlijn L. van Rooijen, Miriam Koopman, Geraldine R. Vink, Remond J. A. Fijneman
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
circulating tumor DNA
circulating cell-free DNA
liquid biopsy
DNA methylation
colorectal cancer
surgery
Online Access:https://www.mdpi.com/2072-6694/14/9/2218

Internet

https://www.mdpi.com/2072-6694/14/9/2218

Similar Items